CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.

1:14-cv-00820

Overview

Case Number 1:14-cv-00820
Filing Date 2014-06-25
Status Terminated
Termination Date 2015-10-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Sami Sedghani

Email: ssedghani@wsgr.com

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Nicole W. Stafford

Email: nstafford@wsgr.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Eric C. Arnell

Email: earnell@wsgr.com

Novartis AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Novartis Corporation Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Novartis Pharmaceuticals Corporation Operating Company

Represented By

8 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Lisa J. Pirozzolo

Email: lisa.pirozzolo@wilmerhale.com

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Shirley Cantin

UNDELIVERABLE EMAIL 10/13/2021

Kevin S. Prussia

Email: kevin.prussia@wilmerhale.com

Kelli J. Powell

Email: kelli.powell@wilmerhale.com

Jane M. Love

Email: jlove@gibsondunn.com

Corinne E. Atton

Email: catton@venable.com

Plaintiff

Novartis Pharma AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Counter Claimant

Mylan Inc. Operating Company

Represented By

5 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Nicole W. Stafford

Email: nstafford@wsgr.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Eric C. Arnell

Email: earnell@wsgr.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2016-07-29
1:16-cv-00648

Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-03-21
1:12-cv-00366

Novartis Pharmaceuticals Corporation v. Actavis Inc

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6465504
Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
Filed: 2000-10-30
Issued: 2002-10-15
Expired (Term Ended)
Expires: 2019-04-05
US6596750
Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
Filed: 2002-09-23
Issued: 2003-07-22
Expired (Term Ended)
Expires: 2022-09-23

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

28

Dispositive

13

Granted

0

Denied

1

Pending / Review

27

Motions by Category

Procedural / Extension Motion 4 Motion to Dismiss 13 Motion to Stay 5 Claim Construction / Markman Filing 6

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
ORDER Denying Mylan Pharmaceuticals Inc.'s Motion to Dismiss (D.I. 14 ); DISMISSING without prejudice Mylan Inc.'s Motion to Dismiss. Plaintiffs are permitted s...
Entry #57 • 2015-03-16 Document →
Motion to Dismiss Pending / Under Review
ORDER regarding the request to argue the effect of Acorda and AstraZeneca on the pending motion to dismiss (see Order for further directives). Signed by Judge R...
Entry #42 • 2015-01-22 Document →
Motion to Dismiss Pending / Under Review
Letter to The Honorable Richard G. Andrews from Richard L. Horwitz, Esquire regarding subsequent authority relevant to Mylan's pending Motion to Dismiss (D.I. 1...
Entry #37 • 2014-11-06 Document →
Motion to Dismiss Pending / Under Review
REQUEST for Oral Argument by Mylan Inc., Mylan Pharmaceuticals Inc. re 14 MOTION to Dismiss. (Moore, David) (Entered: 10/15/2014)
Entry #35 • 2014-10-15 Document →
Motion to Dismiss Pending / Under Review
REQUEST for Oral Argument by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation re 14 MOTION to Dismiss. (Silver, Danie...
Entry #34 • 2014-10-14 Document →
Motion to Dismiss Pending / Under Review
[SEALED] REPLY BRIEF re 14 MOTION to Dismiss for Lack of Personal Jurisdiction filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-N)(M...
Entry #33 • 2014-10-08 Document →

Docket Entries

(119 total)
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1541191.) - filed by Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, Novartis Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cla, ) (Entered: 06/25/2014)

Entry #1 • 2014-06-25
1
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1541191.) - filed by Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, Novartis Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cla, ) (Entered: 06/25/2014)

Entry #1 • 2014-06-25
2
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1541191.) - filed by Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, Novartis Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cla, ) (Entered: 06/25/2014)

Entry #1 • 2014-06-25
2
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1541191.) - filed by Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, Novartis Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cla, ) (Entered: 06/25/2014)

Entry #1 • 2014-06-25
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 06/25/2014)

Entry #2 • 2014-06-25
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc